OBJECTIVE: To determine whether hip fracture patients, a group at very high risk for additional fragility fractures, are being evaluated and treated effectively for osteoporosis. METHODS: Clinical and bone densitometry (dual x-ray absorptiometry [DXA]) records were reviewed in hip fracture patients at 4 Midwestern US health systems to determine the frequency of DXA use, calcium and vitamin D supplementation, and antiresorptive drug treatment. RESULTS: DXA was performed at the 4 study sites in only 12%, 12%, 13%, and 24% of patients, respectively. Calcium and vitamin D supplements were prescribed in 27%, 1%, 3%, and 25% of the patients at the 4 study sites. Antiresorptive drugs were prescribed in 26%, 12%, 7%, and 37% of the patients with only 2-10% receiving a bisphosphonate. CONCLUSION: Reducing osteoporotic fractures will require more effective approaches to managing hip fracture patients and other high-risk populations.
OBJECTIVE: To determine whether hip fracturepatients, a group at very high risk for additional fragility fractures, are being evaluated and treated effectively for osteoporosis. METHODS: Clinical and bone densitometry (dual x-ray absorptiometry [DXA]) records were reviewed in hip fracturepatients at 4 Midwestern US health systems to determine the frequency of DXA use, calcium and vitamin D supplementation, and antiresorptive drug treatment. RESULTS: DXA was performed at the 4 study sites in only 12%, 12%, 13%, and 24% of patients, respectively. Calcium and vitamin D supplements were prescribed in 27%, 1%, 3%, and 25% of the patients at the 4 study sites. Antiresorptive drugs were prescribed in 26%, 12%, 7%, and 37% of the patients with only 2-10% receiving a bisphosphonate. CONCLUSION: Reducing osteoporotic fractures will require more effective approaches to managing hip fracturepatients and other high-risk populations.
Authors: Giuseppe Colì; Massimo Abatelillo; Giuseppe Cataldi; Francesco De Caro; Diego Esposito; Walter Mega; Vinicio Perrone; Prisco Piscitelli; Luigia Manno Journal: Clin Cases Miner Bone Metab Date: 2009-09
Authors: B J Edwards; A D Bunta; J Anderson; A Bobb; A Hahr; K J O'Leary; A Agulnek; L Andruszyn; K A Cameron; M May; N H Kazmers; N Dillon; D W Baker; M V Williams Journal: Osteoporos Int Date: 2012-01-25 Impact factor: 4.507
Authors: Deborah A Levine; Kenneth G Saag; Linda L Casebeer; Cathleen Colon-Emeric; Kenneth W Lyles; Richard M Shewchuk Journal: J Am Med Dir Assoc Date: 2006-07-17 Impact factor: 4.669
Authors: Shuko Nojiri; Russel T Burge; Jennifer A Flynn; Shonda A Foster; Hideaki Sowa Journal: J Bone Miner Metab Date: 2013-03-28 Impact factor: 2.626